182256-19-5

Upstream product

• 182255-94-3 (2S,5R)-6-[1-Carbamoyl-meth-(E)-ylidene]-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid benzyl ester 
• 182256-11-7 (R)-2-[(2R,3R)-2-(Benzothiazol-2-yldisulfanyl)-3-carbamoylmethyl-4-oxo-azetidin-1-yl]-3-methyl-but-3-enoic acid benzyl ester 
• 182256-05-9 (2S,5R,6R)-6-Carbamoylmethyl-3,3-dimethyl-4,7-dioxo-4λ⁴-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid benzyl ester 
• 39126-59-5 6-oxopenicillanic acid benzyl ester 
• 81482-49-7 benzyl 6-β-amidopenicillanate 
• 182256-15-1 (2S,3R,5R,6R)-6-Carbamoylmethyl-3-chloromethyl-3-methyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid benzyl ester 

Relevant academic research and scientific papers

Synthesis and antimicrobial evaluation of 2β-chloromethyl-6β-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid

A new 2β-Chloromethyl-6β-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid was synthesised and evaluated for its antimicrobial and β-lactamase inhibitory activity. The compound was found to be inactive.